AI assistant
NEOGENOMICS INC — Director's Dealing 2024
May 3, 2024
32227_dirs_2024-05-03_d8164254-ae1e-4965-8403-14581b6dc956.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2024-05-01
Reporting Person: Aunan Greg D (Chief Accounting Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-05-01 | Common Stock | F | 937 | — | Disposed | 14453 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-05-02 | Stock Option (Right to Buy) | $13.96 | A | 26978 | Acquired | 2034-05-02 | Common Stock (26978) | Direct |
| 2024-05-02 | Restricted Stock Unit | $0 | A | 16117 | Acquired | Common Stock (16117) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $14.62 | 2030-05-01 | Common Stock (28662) | 28662 | Direct |
Footnotes
F1: Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the May 1, 2024 vesting of restricted stock.
F2: On May 1, 2023, Mr. Aunan was granted 28,662 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F3: On May 2, 2024, Mr. Aunan was granted 26,978 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F4: On May 2, 2024, Mr. Aunan was granted 16,117 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
F5: Once vested, the shares of common stock are not subject to expiration.